179 related articles for article (PubMed ID: 32471161)
21. Rictor-dependent AKT activation and inhibition of urothelial carcinoma by rapamycin.
Wu MJ; Chang CH; Chiu YT; Wen MC; Shu KH; Li JR; Chiu KY; Chen YT
Urol Oncol; 2012; 30(1):69-77. PubMed ID: 20207175
[TBL] [Abstract][Full Text] [Related]
22. Pre-clinical and clinical significance of heparanase in Ewing's sarcoma.
Shafat I; Ben-Arush MW; Issakov J; Meller I; Naroditsky I; Tortoreto M; Cassinelli G; Lanzi C; Pisano C; Ilan N; Vlodavsky I; Zunino F
J Cell Mol Med; 2011 Sep; 15(9):1857-64. PubMed ID: 21029368
[TBL] [Abstract][Full Text] [Related]
23. Heparanase promotes glioma progression via enhancing CD24 expression.
Barash U; Spyrou A; Liu P; Vlodavsky E; Zhu C; Luo J; Su D; Ilan N; Forsberg-Nilsson K; Vlodavsky I; Yang X
Int J Cancer; 2019 Sep; 145(6):1596-1608. PubMed ID: 31032901
[TBL] [Abstract][Full Text] [Related]
24. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate.
Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T
J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189
[TBL] [Abstract][Full Text] [Related]
25. Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype.
Purushothaman A; Hurst DR; Pisano C; Mizumoto S; Sugahara K; Sanderson RD
J Biol Chem; 2011 Sep; 286(35):30377-30383. PubMed ID: 21757697
[TBL] [Abstract][Full Text] [Related]
26. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis.
Yang Y; Macleod V; Miao HQ; Theus A; Zhan F; Shaughnessy JD; Sawyer J; Li JP; Zcharia E; Vlodavsky I; Sanderson RD
J Biol Chem; 2007 May; 282(18):13326-33. PubMed ID: 17347152
[TBL] [Abstract][Full Text] [Related]
27. The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.
Ramani VC; Purushothaman A; Stewart MD; Thompson CA; Vlodavsky I; Au JL; Sanderson RD
FEBS J; 2013 May; 280(10):2294-306. PubMed ID: 23374281
[TBL] [Abstract][Full Text] [Related]
28. SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.
Ritchie JP; Ramani VC; Ren Y; Naggi A; Torri G; Casu B; Penco S; Pisano C; Carminati P; Tortoreto M; Zunino F; Vlodavsky I; Sanderson RD; Yang Y
Clin Cancer Res; 2011 Mar; 17(6):1382-93. PubMed ID: 21257720
[TBL] [Abstract][Full Text] [Related]
29. Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.
Sanderson RD; Elkin M; Rapraeger AC; Ilan N; Vlodavsky I
FEBS J; 2017 Jan; 284(1):42-55. PubMed ID: 27758044
[TBL] [Abstract][Full Text] [Related]
30. The importance of integrin-linked kinase in the regulation of bladder cancer invasion.
Matsui Y; Assi K; Ogawa O; Raven PA; Dedhar S; Gleave ME; Salh B; So AI
Int J Cancer; 2012 Feb; 130(3):521-31. PubMed ID: 21351095
[TBL] [Abstract][Full Text] [Related]
31. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
32. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
33. Screening and identification of novel B cell epitopes in human heparanase and their anti-invasion property for hepatocellular carcinoma.
Yang JM; Wang HJ; Du L; Han XM; Ye ZY; Fang Y; Tao HQ; Zhao ZS; Zhou YL
Cancer Immunol Immunother; 2009 Sep; 58(9):1387-96. PubMed ID: 19169879
[TBL] [Abstract][Full Text] [Related]
34. Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway.
Yu S; Lv H; Zhang H; Jiang Y; Hong Y; Xia R; Zhang Q; Ju W; Jiang L; Ou G; Zhang J; Wang S; Zhang J
Biochem Biophys Res Commun; 2017 Apr; 485(2):432-439. PubMed ID: 28209511
[TBL] [Abstract][Full Text] [Related]
35. Starvation-induced autophagy promotes the invasion and migration of human bladder cancer cells via TGF-β1/Smad3-mediated epithelial-mesenchymal transition activation.
Tong H; Yin H; Hossain MA; Wang Y; Wu F; Dong X; Gao S; Zhan K; He W
J Cell Biochem; 2019 Apr; 120(4):5118-5127. PubMed ID: 30320898
[TBL] [Abstract][Full Text] [Related]
36. Heparanase mediates cell adhesion independent of its enzymatic activity.
Goldshmidt O; Zcharia E; Cohen M; Aingorn H; Cohen I; Nadav L; Katz BZ; Geiger B; Vlodavsky I
FASEB J; 2003 Jun; 17(9):1015-25. PubMed ID: 12773484
[TBL] [Abstract][Full Text] [Related]
37. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
[TBL] [Abstract][Full Text] [Related]
38. Heparanase overexpression down-regulates syndecan-1 expression in a gallbladder carcinoma cell line.
Jin H; Zhou S; Yang S; Cao HM
J Int Med Res; 2017 Apr; 45(2):662-672. PubMed ID: 28351285
[TBL] [Abstract][Full Text] [Related]
39. Heparanase protein and gene expression in bladder cancer.
Gohji K; Okamoto M; Kitazawa S; Toyoshima M; Dong J; Katsuoka Y; Nakajima M
J Urol; 2001 Oct; 166(4):1286-90. PubMed ID: 11547059
[TBL] [Abstract][Full Text] [Related]
40. Heparanase promotes lymphangiogenesis and tumor invasion in pancreatic neuroendocrine tumors.
Hunter KE; Palermo C; Kester JC; Simpson K; Li JP; Tang LH; Klimstra DS; Vlodavsky I; Joyce JA
Oncogene; 2014 Apr; 33(14):1799-808. PubMed ID: 23644656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
